Bakkt Holdings
BKKT
Bit Origin
BTOG
Intchains Group
ICG
Mawson Infrastructure
MIGI
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
TVTX Travere Therapeutic
- 20.830
- +0.130+0.63%
Close Mar 20 16:00 ET
- 20.820
- -0.010-0.05%
Post 18:57 ET
1.85BMarket Cap-5.11P/E (TTM)
20.980High20.420Low803.47KVolume20.490Open20.700Pre Close16.68MTurnover1.06%Turnover RatioLossP/E (Static)88.74MShares25.29052wk High31.28P/B1.57BFloat Cap5.12052wk Low--Dividend TTM75.50MShs Float37.040Historical High--Div YieldTTM2.71%Amplitude0.000Historical Low20.756Avg Price1Lot Size
About Travere Therapeutic Company
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
Company Profile
SymbolTVTX
Company NameTravere Therapeutic
Listing DateJan 10, 2014
Founded2008
CEODr. Eric M. Dube, PhD
MarketNASDAQ
Employees385
Fiscal Year Ends12-31
Address3611 Valley Centre Drive,Suite 300
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-888-969-7879
Websitehttp://www.travere.com
Company Executives
- Name
- Position
- Salary
- Dr. Eric M. Dube, PhD
- Director, President and Chief Executive Officer
- 7.57M
- Sandra Calvin
- Senior Vice President and Chief Accounting Officer
- --
- Christopher Cline
- Chief Financial Officer
- 1.97M
- Peter Heerma
- Chief Commercial Officer
- 2.00M
- Dr. Jula Inrig
- Chief Medical Officer
- --
- William E. Rote
- Senior Vice President, Research and Development
- 2.05M
- Elizabeth E. Reed
- Senior Vice President, General Counsel and Corporate Secretary
- 2.02M
- Gary A. Lyons
- Chairman of the Board
- 392.98K
- Timothy P. Coughlin
- Independent Director
- 385.48K
- Dr. Suzanne L. Bruhn, PhD
- Independent Director
- 372.36K
- Ruth WilliaBrinkley
- Independent Director
- 365.48K
- Ron Squarer
- Independent Director
- 367.98K
- Jeffrey A. Meckler
- Independent Director
- 379.98K
- Sandra E. Poole
- Independent Director
- 369.86K
- Dr. Roy D. Baynes, M.D.,PhD
- Independent Director
- 376.73K
- John A. Orwin, M.B.A.
- Independent Director
- 372.98K
Market Insights
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.